Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Do bioprosthetic aortic valves deteriorate more rapidly in patients with the metabolic syndrome?

Nature Clinical Practice Cardiovascular Medicine volume 4, pages 192–193 (2007)Cite this article

boxed-textBriand M et al. (2006) Metabolic syndrome is associated with faster degeneration of biprosthetic valves. Circulation 114 (Suppl I): I512–I517

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. O'Brien KD (2006) Pathogenesis of calcific aortic valve disease: a disease process comes of age (and a good deal more). Arterioscler Thromb Vasc Biol 26: 1721–1728

    Article  CAS  Google Scholar 

  2. Bonow RO et al. (2006) ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 114: e84–e231

    Article  Google Scholar 

  3. Cowell SJ et al. for the Scottish Aortic Stenosis and Lipid Lowering Trial, Impact on Regression (SALTIRE) Investigators (2005) A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 352: 2389–2397

    Article  CAS  Google Scholar 

  4. Eckel RH et al. (2005) The metabolic syndrome. Lancet 365: 1415–1428

    Article  CAS  Google Scholar 

  5. Katz R et al. (2006) Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 113: 2113–2119

    Article  Google Scholar 

  6. Briand M et al. (2006) Metabolic syndrome negatively influences disease progression and prognosis in aortic stenosis. J Am Coll Cardiol 47: 2229–2236

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Alexandra King, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Division of Cardiology, University of Washington, Box 356422, 1959 NE Pacific Street, Seattle, WA 98195-66422, USA cardiac@u.washington.edu

Authors and Affiliations

  1. KD O'Brien is an Associate Professor of Medicine in the Division of Cardiology, at the University of Washington, Seattle, WA, USA.,

    Kevin D O'Brien

Authors
  1. Kevin D O'Brien
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

KD O'Brien has received speaker honoraria from Merck and Takeda and consultancy fees from Novartis and Sanofi-Aventis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

O'Brien, K. Do bioprosthetic aortic valves deteriorate more rapidly in patients with the metabolic syndrome?. Nat Rev Cardiol 4, 192–193 (2007). https://doi.org/10.1038/ncpcardio0826

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpcardio0826

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing